JP Morgan Chase
GNOM icon

JP Morgan Chase’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

JP Morgan Chase’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Hold
0
– – – 7018
2025
Q1 		– Hold
0
– – – 7264
2024
Q4 		– Hold
0
– – – 7359
2024
Q3 		– Hold
0
– – – 7352
2024
Q2 		– Sell
-63
Closed -$3 – 7522
2024
Q1 		$3 Buy
+63
New +$2.87K ﹤0.01% 7293
2023
Q4 		– Sell
-111
Closed -$4.53K – 7656
2023
Q3 		$4.5K Buy
+111
New +$5.05K ﹤0.01% 6390
2023
Q2 		– Hold
0
– – – 6854
2023
Q1 		– Hold
0
– – – 6638

Other funds holding GNOM

FTUS
Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
IA
Insight Advisors Newtown, Pennsylvania $567M AUM 25.52% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return
OCM
One Capital Management Westlake Village, California $3.6B AUM 16.02% 1-Year Est. Return

JP Morgan Chase's GNOM Position: Q2 2025 in Review

JP Morgan Chase held its Global X Genomics & Biotechnology ETF (GNOM) position steady in Q2 2025 at 0 shares worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #7018.

JP Morgan Chase first reported a position in GNOM in Q3 2023 and has held it in 2 quarters since. The position peaked at $4.5K in Q3 2023. 53 funds tracked by Wall St. Rank hold GNOM as of Q2 2025.

  • JP Morgan Chase held 0 shares of Global X Genomics & Biotechnology ETF worth $1 as of Q2 2025.
  • JP Morgan Chase left its Global X Genomics & Biotechnology ETF share count unchanged in Q2 2025.
  • Global X Genomics & Biotechnology ETF made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2025, its #7018 holding.
  • JP Morgan Chase first reported a position in Global X Genomics & Biotechnology ETF in Q3 2023 and has held it in 2 quarters since.
  • JP Morgan Chase's Global X Genomics & Biotechnology ETF position peaked at $4.5K in Q3 2023.
  • 53 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2025.

Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.